Why the study?
Does thinner coronary stent strut thickness reduce the incidences of clinical outcomes after drug-eluting stent implantation?
Does thinner coronary stent strut thickness reduce the incidences of clinical outcomes after drug-eluting stent implantation?
Thinner stent struts in drug-eluting stents are associated with fewer early adverse events up to 1 year, but do not significantly impact late events up to 5 years.
Answers are grounded in this paper and cite their sources.
Supports thinner-strut DES to reduce early events; extends evidence by showing no late benefit up to 5 years.
In this meta-regression analysis, a thinner strut thickness was associated with reduced incidences of early stent-related adverse events (1-year TLR, PMI, and early ST), but not with later events (5-year TLR, late ST, and very late ST).
No takes yet. Share an insight, caveat, or question.
Saito et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: